Prognostic factors and risk-stratification model of recurrent or metastatic head and neck squamous cell carcinoma treated with cetuximab containing regimen - Yang, Muh-Hwa; Chen, Tien-Hua; Wang, Hung-Ming; Hsieh, Jason Chia-Hsun; Huang, Huai-Cheng; Hsieh, Meng-Che; Yen, Chia-Jui; Wu, Shang-Yin; Hua, Chun-Hung; Lien, Ming-Yu; Chang, Yi-Fang; Wang, Hui-Ching; et al. (BMC cancer, 2024)
Keywords: Adult; Aged; Alcohol; Alcohol use; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Biochemistry; Blood cell count; Blood levels; Cancer; Cancer therapies; Care and treatment; Cell number; Cetuximab; Cetuximab - administration & dosage; Cetuximab - therapeutic use; Chemotherapy; Clinical outcomes; Drug development; Female; Head & neck cancer; Head and neck cancer; Head and neck carcinoma; Head and Neck Neoplasms - drug therapy; Head and Neck Neoplasms - mortality; Head and Neck Neoplasms - pathology; Head and neck squamous cell carcinoma; Health aspects; Hematology; Hemoglobin; Human papillomavirus; Humans; Induction therapy; Leukocytes (neutrophilic); Lymphocytes; Male; Medical centers; Medical prognosis; Medical research; Medicine, Experimental; Metastases; Metastasis; Middle Aged; Monoclonal antibodies; Multivariate analysis; Neoplasm Recurrence, Local; Neutrophils; Patients; Population studies; Prediction models; Prevention; Prognosis; Prognostic factor; Radiation therapy; Radiotherapy; Relapse; Response rates; Retrospective Studies; Risk Assessment - methods; Risk Factors; Risk groups; Risk-stratification model; Squamous cell carcinoma; Squamous Cell Carcinoma of Head and Neck - drug therapy; Squamous Cell Carcinoma of Head and Neck - mortality; Squamous Cell Carcinoma of Head and Neck - pathology; Statistical significance; Surgery; Survival analysis; Taiwan - epidemiology; Targeted cancer therapy; Variables; Taiwan; Prognostic factor; Head and neck squamous cell carcinoma; Cetuximab; Risk-stratification model